Yonghan Hu

Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

Yonghan Hu, Jason Xiang, Martin DiGrandi et al. · Bioorganic & Medicinal Chemistry · 2005 · 107 citations

Medicine, Chronic Musculoskeletal Condition, Osteoarthritis +3

Indole Cytosolic Phospholipase A₂α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1<i>H</i>-indol-3-yl]propyl}benzoic Acid, Efipladib

John C. McKew, Katherine L. Lee, Marina W. H. Shen et al. · Journal of Medicinal Chemistry · 2008 · 88 citations

Novel Polymer-Supported Trialkylsilanes and Their Use in Solid-Phase Organic Synthesis

Yonghan Hu, John A. Porco, Jeff W. Labadie et al. · The Journal of Organic Chemistry · 1998 · 84 citations

Macromolecular Chemistry, Engineering, Altmetric Attention Score +16

Pharmacologic Inhibition of Tpl2 Blocks Inflammatory Responses in Primary Human Monocytes, Synoviocytes, and Blood

J. Perry Hall, Yahya Kurdi, Sang Hsu et al. · Journal of Biological Chemistry · 2007 · 76 citations · Full text

Synthesis and SAR of highly selective MMP-13 inhibitors

Jianchang Li, Thomas S. Rush, Wěi Li et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 63 citations · Full text

Medicinal Chemistry, Medicine, Selective Mmp-13 Inhibitors +4